Eiko LifeSciences Limited, together with its subsidiary, manufactures and sells specialty and fine chemicals in India and internationally. It operates through Agrochemicals; Oleo Chemicals; Pharmaceuticals; Food Additives; Clinical Research, Development; and Logistics segments. It also offers cosmetic emollients, and flavor and fragrances. In addition, the company is involved in manufacturing, suppling, and exporting of specialty chemicals, fine chemicals, and pharma intermediates; acquiring, manufacturing, leasing, and renting, and managing shipping containers; and clinical research, development, and innovation within the specialty chemicals, healthcare, and other medical fields. Its products are used in pharmaceuticals, agrochemicals, aroma chemicals, consumer goods, and electronic chemicals. The company also export its products. The company was formerly known as Narendra Investments (Delhi) Limited and changed its name to Eiko LifeSciences Limited in June 2021. Eiko LifeSciences Lim
| Current Price | ₹52.95 |
|---|---|
| Market Cap | ₹76 Cr |
| Sector | Materials > Materials > Chemicals |
| Sub-Industry | Specialty Chemicals > 0 |
| P/E Ratio | 16.6 |
| Return on Equity | 8.40% |
| 52-Week Range | ₹45.90 – ₹65.90 |
| Beta (1Y) | 0.44 |
| Dividend Yield | 0.00% |
Eiko Lifesciences Ltd is trading at ₹52.95, with a market capitalisation of ₹76 Cr.
Eiko Lifesciences Ltd operates in the Materials > Materials > Chemicals space (Specialty Chemicals > 0).
Eiko Lifesciences Ltd has a P/E of 16.6 and a return on equity of 8.40%.